These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 3579908)
81. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Marshall BJ; Warren JR Lancet; 1984 Jun; 1(8390):1311-5. PubMed ID: 6145023 [TBL] [Abstract][Full Text] [Related]
82. Campylobacter pyloridis: the rediscovery of a forgotten bacterium. Pattyn SR; De Bruyn EJ; Van Caekenberghe DL Verh K Acad Geneeskd Belg; 1987; 49(5):392-411. PubMed ID: 3321742 [No Abstract] [Full Text] [Related]
83. Campylobacter pylori: associations with antral and fundic mucosal histology and diagnosis by serology in patients with upper gastrointestinal symptoms. Cohen H; Gramisu M; Fitzgibbons P; Appleman M; Skoglund M; Valenzuela JE Am J Gastroenterol; 1989 Apr; 84(4):367-71. PubMed ID: 2648815 [TBL] [Abstract][Full Text] [Related]
84. [Campylobacter pyloridis (Cp) infection of gastric mucosa in the high and low risk areas of gastric cancer in Liaoning province]. Lin HZ Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):365-7. PubMed ID: 2620634 [TBL] [Abstract][Full Text] [Related]
85. [Detection of Campylobacter pylori in gastric mucosa--relation to gastroscopy findings and degree of gastritis]. Häntzschel U; Mehlhorn J; Schreckenbach U; Voigt HU Gastroenterol J; 1990; 50(4):163-8. PubMed ID: 2091669 [TBL] [Abstract][Full Text] [Related]
88. The adherent gastric mucus gel barrier in man and changes in peptic ulceration. Allen A; Cunliffe WJ; Pearson JP; Venables CW J Intern Med Suppl; 1990; 732():83-90. PubMed ID: 2200418 [TBL] [Abstract][Full Text] [Related]
89. [Study of leukotriene B4 level in gastric mucosa of patients with Campylobacter pylori gastritis]. Kimura S; Arakawa T; Nebiki H; Sakuma H; Fukuda T Nihon Shokakibyo Gakkai Zasshi; 1988 Nov; 85(11):2472. PubMed ID: 2851669 [No Abstract] [Full Text] [Related]
90. Effect of acetylsalicylic acid on gastric mucin viscosity, permeability to hydrogen ion, and susceptibility to pepsin. Sarosiek J; Mizuta K; Slomiany A; Slomiany BL Biochem Pharmacol; 1986 Dec; 35(23):4291-5. PubMed ID: 3098249 [TBL] [Abstract][Full Text] [Related]
91. Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer. Liu F; Fu J; Bergstrom K; Shan X; McDaniel JM; McGee S; Bai X; Chen W; Xia L J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31645367 [TBL] [Abstract][Full Text] [Related]
92. Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content. Megraud F; Bonnet F; Garnier M; Lamouliatte H J Clin Microbiol; 1985 Dec; 22(6):1007-10. PubMed ID: 4066910 [TBL] [Abstract][Full Text] [Related]
93. Gastric mucus degradation in vivo in peptic ulcer patients and the effects of vagotomy. Younan F; Pearson JP; Allen A; Venables CW Adv Exp Med Biol; 1982; 144():235-7. PubMed ID: 7044060 [No Abstract] [Full Text] [Related]
94. Effect of pepsin on partially purified pig gastric mucus and purified mucin. Lee SP; Nicholls JF; Roberton AM; Park HZ Biochem Cell Biol; 1988 May; 66(5):367-73. PubMed ID: 2457383 [TBL] [Abstract][Full Text] [Related]
95. Gastric mucus and the gastric mucous barrier. A review. Menguy R Am J Surg; 1969 Jun; 117(6):806-12. PubMed ID: 4308396 [No Abstract] [Full Text] [Related]